Baricitinib vs Ipilimumab

## Baricitinib vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Baricitinib** and **Ipilimumab**.

## Mechanism of Action

**Baricitinib**: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Baricitinib — 12 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Baricitinib — C16H17N7O2S; Ipilimumab — N/A.

**Molecular Weight**: Baricitinib — 371.4170 g/mol; Ipilimumab — N/A.

**Type**: Baricitinib — Small molecule; Ipilimumab — Antibody.